✦ LIBER ✦

Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox®) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum

✍ Scribed by Sheng-Mou Hsiao; Chi-An Chen; Ho-Hsiung Lin; Chang-Yao Hsieh; Lin-Hung Wei

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Final overall survival results of phase

✍ Wagner, U; Marth, C; Largillier, R; Kaern, J; Brown, C; Heywood, M; Bonaventura, 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 242 KB

A phase II clinical trial of pegylated l

✍ Marcela G. del Carmen; John Micha; Laurie Small; Daron G. Street; Anil Londhe; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Carboplatin and pegylated liposomal doxo

✍ Gladieff, L.; Ferrero, A.; De Rauglaudre, G.; Brown, C.; Vasey, P.; Reinthaller, 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 124 KB

926 POSTER Phase II austrian AGO study o

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Salvage chemotherapy with docetaxel and

✍ Koinis, Filippos; Polyzos, Aristidis; Christopoulou, Athina; Zafeiriou, Zafeiris 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 254 KB

8025 Correlation of Topo II alpha expres

✍ Gonzalez-Martin, A.; Casado, A.; Blanco-Sanchez, I.; Bover, I.; Herrero, A.; San 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB